DD150061A5 - Verfahren zur herstellung von neuen benzo-as-triazin-derivaten - Google Patents

Verfahren zur herstellung von neuen benzo-as-triazin-derivaten Download PDF

Info

Publication number: DD150061A5
Authority: DD; German Democratic Republic
Prior art keywords: triazine; general formula; triazolo; dihydro; c7benzo
Prior art date: 1979-04-11

Application number

DD80220282A

Other languages

German (de)

English (en)

Inventor

Gyoergy Hajos

Andras Messmer

Pal Benko

Lujza Petoecz

Peter Goeroeg

Ibolya Kosoczky

Original Assignee

Egyt Gyogyszervegyeszeti Gyar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-04-11

Filing date

1980-04-08

Publication date

1981-08-12

1980-04-08 Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar

1981-08-12 Publication of DD150061A5 publication Critical patent/DD150061A5/de

Links

238000002360 preparation method Methods 0.000 title claims abstract description 31
238000000034 method Methods 0.000 title claims abstract description 23
FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract description 46
239000002253 acid Substances 0.000 claims abstract description 22
150000003839 salts Chemical class 0.000 claims abstract description 18
GDAXJBDYNVDMDF-UHFFFAOYSA-N 1,2,4-benzotriazine Chemical class N1=NC=NC2=CC=CC=C21 GDAXJBDYNVDMDF-UHFFFAOYSA-N 0.000 claims abstract description 6
239000003795 chemical substances by application Substances 0.000 claims description 21
-1 pyrazinylcarbonyl Chemical group 0.000 claims description 17
239000001257 hydrogen Substances 0.000 claims description 16
229910052739 hydrogen Inorganic materials 0.000 claims description 16
125000000217 alkyl group Chemical group 0.000 claims description 11
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
229910052736 halogen Inorganic materials 0.000 claims description 8
150000002431 hydrogen Chemical class 0.000 claims description 8
230000007062 hydrolysis Effects 0.000 claims description 8
238000006460 hydrolysis reaction Methods 0.000 claims description 8
125000003545 alkoxy group Chemical group 0.000 claims description 7
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
150000002367 halogens Chemical class 0.000 claims description 7
230000036961 partial effect Effects 0.000 claims description 7
230000010933 acylation Effects 0.000 claims description 6
238000005917 acylation reaction Methods 0.000 claims description 6
125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
239000007858 starting material Substances 0.000 claims description 6
125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 claims description 4
SGEAPMBJSKNHBX-UHFFFAOYSA-N pyrazole-3,5-dione Chemical group O=C1CC(=O)N=N1 SGEAPMBJSKNHBX-UHFFFAOYSA-N 0.000 claims description 4
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
230000001588 bifunctional effect Effects 0.000 claims description 3
239000011230 binding agent Substances 0.000 claims description 3
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
125000005843 halogen group Chemical group 0.000 claims description 2
150000003840 hydrochlorides Chemical class 0.000 claims description 2
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 2
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 16
230000000694 effects Effects 0.000 abstract description 7
229960000583 acetic acid Drugs 0.000 abstract description 6
230000003444 anaesthetic effect Effects 0.000 abstract description 3
230000000202 analgesic effect Effects 0.000 abstract description 3
MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 abstract description 2
239000005557 antagonist Substances 0.000 abstract description 2
239000012362 glacial acetic acid Substances 0.000 abstract description 2
229960005333 tetrabenazine Drugs 0.000 abstract description 2
WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
238000001819 mass spectrum Methods 0.000 description 15
239000000047 product Substances 0.000 description 12
239000011541 reaction mixture Substances 0.000 description 12
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
239000000203 mixture Substances 0.000 description 8
WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 7
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 5
239000012346 acetyl chloride Substances 0.000 description 5
229910052786 argon Inorganic materials 0.000 description 5
239000000825 pharmaceutical preparation Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
229910001868 water Inorganic materials 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
239000000126 substance Substances 0.000 description 4
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
230000001741 anti-phlogistic effect Effects 0.000 description 3
238000009835 boiling Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000002252 acyl group Chemical group 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
239000002260 anti-inflammatory agent Substances 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000008018 melting Effects 0.000 description 2
238000002844 melting Methods 0.000 description 2
229960004815 meprobamate Drugs 0.000 description 2
229960005489 paracetamol Drugs 0.000 description 2
229960002895 phenylbutazone Drugs 0.000 description 2
VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
150000000185 1,3-diols Chemical class 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
ITTFEPALADGOBD-UHFFFAOYSA-N 2-butylpropanedioyl dichloride Chemical compound CCCCC(C(Cl)=O)C(Cl)=O ITTFEPALADGOBD-UHFFFAOYSA-N 0.000 description 1
VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
MLNSYGKGQFHSNI-UHFFFAOYSA-N 2-propylpropanedioyl dichloride Chemical compound CCCC(C(Cl)=O)C(Cl)=O MLNSYGKGQFHSNI-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000700159 Rattus Species 0.000 description 1
PSIWVYDKSVQMGM-UHFFFAOYSA-L S(=O)([O-])S(=O)[O-].[Na+].[Na+].[Na+] Chemical compound S(=O)([O-])S(=O)[O-].[Na+].[Na+].[Na+] PSIWVYDKSVQMGM-UHFFFAOYSA-L 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
229960001138 acetylsalicylic acid Drugs 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000003513 alkali Substances 0.000 description 1
229910001854 alkali hydroxide Inorganic materials 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
OMRYJSVAHRNTGC-UHFFFAOYSA-N benzene triazine Chemical class C1=CC=CC=C1.C1=CN=NN=C1 OMRYJSVAHRNTGC-UHFFFAOYSA-N 0.000 description 1
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
125000002587 enol group Chemical group 0.000 description 1
RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
UYXAWHWODHRRMR-UHFFFAOYSA-N hexobarbital Chemical compound O=C1N(C)C(=O)NC(=O)C1(C)C1=CCCCC1 UYXAWHWODHRRMR-UHFFFAOYSA-N 0.000 description 1
229960002456 hexobarbital Drugs 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
235000014380 magnesium carbonate Nutrition 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
125000005400 pyridylcarbonyl group Chemical group N1=C(C=CC=C1)C(=O)* 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DD80220282A 1979-04-11 1980-04-08 Verfahren zur herstellung von neuen benzo-as-triazin-derivaten DD150061A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU79EE2646A HU179158B (en)	1979-04-11	1979-04-11	Process for producing triasolo-benzo-asimetrical-triasine derivatives

Publications (1)

Publication Number	Publication Date
DD150061A5 true DD150061A5 (de)	1981-08-12

Family

ID=10995838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD80220282A DD150061A5 (de)	1979-04-11	1980-04-08	Verfahren zur herstellung von neuen benzo-as-triazin-derivaten

Country Status (16)

Country	Link
US (1)	US4316022A (fr)
AT (1)	AT380255B (fr)
AU (1)	AU534271B2 (fr)
BE (1)	BE882675A (fr)
CH (1)	CH644125A5 (fr)
DD (1)	DD150061A5 (fr)
DE (1)	DE3014011A1 (fr)
ES (1)	ES490505A0 (fr)
FR (1)	FR2453861A1 (fr)
GB (1)	GB2047693B (fr)
GR (1)	GR68093B (fr)
HU (1)	HU179158B (fr)
IT (1)	IT1212412B (fr)
NL (1)	NL8002120A (fr)
SU (2)	SU1187722A3 (fr)
YU (1)	YU100180A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5624925A (en)	1986-09-25	1997-04-29	Sri International	1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
US5175287A (en) *	1986-09-25	1992-12-29	S R I International	Process for preparing 1,2,4-benzotriazine oxides
CA2319435A1 (fr) *	1998-12-04	2000-06-15	Toray Industries, Inc.	Derives triazolo, et inhibiteurs de chimiokines contenant ces derives comme ingredient actif
US6833454B1 (en)	2003-01-15	2004-12-21	The United States Of America As Represented By The Secretary Of The Navy	Chemical compounds containing bis(triazolo)triazine structures and methods thereof
EP1502918A1 (fr)	2003-07-31	2005-02-02	Bayer CropScience GmbH	Utilisation de dérivés de 1,2,4-benzotriazines comme herbicides et regulateurs de la croissance vegetale, composés et compositions et leurs préparations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3933816A (en) *	1974-09-12	1976-01-20	The Upjohn Company	3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines
US4017492A (en) *	1976-04-02	1977-04-12	The Upjohn Company	As-triazinobenzodiazepin-1-ones

1979
- 1979-04-11 HU HU79EE2646A patent/HU179158B/hu not_active IP Right Cessation
1980
- 1980-03-28 US US06/135,143 patent/US4316022A/en not_active Expired - Lifetime
- 1980-03-31 GB GB8010792A patent/GB2047693B/en not_active Expired
- 1980-04-02 GR GR61603A patent/GR68093B/el unknown
- 1980-04-03 SU SU802902200A patent/SU1187722A3/ru active
- 1980-04-08 BE BE1/9779A patent/BE882675A/fr not_active IP Right Cessation
- 1980-04-08 DD DD80220282A patent/DD150061A5/de unknown
- 1980-04-10 FR FR8008051A patent/FR2453861A1/fr active Granted
- 1980-04-10 IT IT8021284A patent/IT1212412B/it active
- 1980-04-10 AU AU57301/80A patent/AU534271B2/en not_active Ceased
- 1980-04-10 CH CH274180A patent/CH644125A5/de not_active IP Right Cessation
- 1980-04-11 NL NL8002120A patent/NL8002120A/nl not_active Application Discontinuation
- 1980-04-11 AT AT0197380A patent/AT380255B/de not_active IP Right Cessation
- 1980-04-11 DE DE19803014011 patent/DE3014011A1/de not_active Withdrawn
- 1980-04-11 YU YU01001/80A patent/YU100180A/xx unknown
- 1980-04-11 ES ES490505A patent/ES490505A0/es active Granted
1982
- 1982-02-18 SU SU823393298A patent/SU1234401A1/ru active

Also Published As

Publication number	Publication date
YU100180A (en)	1983-09-30
GB2047693A (en)	1980-12-03
AU534271B2 (en)	1984-01-12
ES8104807A1 (es)	1981-04-16
CH644125A5 (de)	1984-07-13
BE882675A (fr)	1980-10-08
ES490505A0 (es)	1981-04-16
AU5730180A (en)	1980-10-16
FR2453861A1 (fr)	1980-11-07
ATA197380A (de)	1985-09-15
IT1212412B (it)	1989-11-22
IT8021284A0 (it)	1980-04-10
GB2047693B (en)	1983-05-25
SU1234401A1 (ru)	1986-05-30
FR2453861B1 (fr)	1983-06-24
HU179158B (en)	1982-08-28
US4316022A (en)	1982-02-16
NL8002120A (nl)	1980-10-14
DE3014011A1 (de)	1980-11-27
GR68093B (fr)	1981-10-30
AT380255B (de)	1986-05-12
SU1187722A3 (ru)	1985-10-23

Publication	Publication Date	Title
DE60007329T2 (de)	2004-06-09	N-heterozyklische derivate als nos inhibitoren
DE2940483C2 (fr)	1989-06-22
AT390732B (de)	1990-06-25	Pharmazeutika enthaltend pyrazole
WO2003020722A1 (fr)	2003-03-13	Nouvelles dihydropteridinones, procedes pour les produire et leur utilisation en tant que medicaments
DE3685604T2 (de)	1993-01-28	1,7-naphthyridinderivate und diese enthaltende arzneimittel.
EP0000220B1 (fr)	1981-04-29	Dihydrouraciles, procédé pour leur préparation et médicaments les contenant
DE68925270T2 (de)	1996-06-13	Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
EP0217372B1 (fr)	1991-01-16	Dérivés de labdane polyoxygénés, leur procédé de préparation et leur utilisation comme médicaments
EP0023707B1 (fr)	1986-04-30	Composés tétraazatricycliques substitués, procédé pour leur préparation, leur application et médicaments les contenant
DD263772A5 (de)	1989-01-11	Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
DE2712023A1 (de)	1977-10-06	Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE2628189A1 (de)	1977-01-20	3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4086353A (en)	1978-04-25	Certain azolinylamino (azolidinylimino) indazoles
DD150061A5 (de)	1981-08-12	Verfahren zur herstellung von neuen benzo-as-triazin-derivaten
DE2429290A1 (de)	1975-01-16	Tricyclische kondensierte imidazolderivate und verfahren zu ihrer herstellung
EP0057428B1 (fr)	1985-04-10	Pyrroles tricycliques, procédé pour leur préparation, leur application et compositions pharmaceutiques les contenant
DD213216A5 (de)	1984-09-05	Verfahren zur herstellung eines neuen pynolidin-derivates
CH493467A (de)	1970-07-15	Verfahren zur Herstellung von Dibenzosuberenderivaten
DE69230110T2 (de)	2000-06-15	An drei ringen substituierte tetrahydropyridin-derivate
EP0110298B1 (fr)	1988-06-01	Dérivés d'acridanone
DE2503436A1 (de)	1975-08-07	2-substituierte 4,5-diphenylthiazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3040085C2 (fr)	1989-11-16
DE69310186T2 (de)	1997-11-27	1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel
AT346841B (de)	1978-11-27	Verfahren zur herstellung von neuen 3- phenylindolinen und ihren salzen
EP0004904B1 (fr)	1981-07-29	Dérivés de 2-amino-3a,4,5,6-tétrahydropérimidine, médicaments les contenant et procédé pour leur préparation